Medicare Coverage Of PET Pharmaceutical Agents Needs Revamp, Industry Says

A broad range of stakeholders are asking CMS to remove national non-coverage language for newly approved radiopharmaceuticals used in positron emission tomography to allow speedier access to new tools for diagnosing Alzheimer’s and other diseases.